The mission of the MCA’s Clinical Trials Consortium is to cultivate, expand, and accelerate our region’s infrastructure and competitiveness in research and innovation.
To be a significant contributor to the global healthcare community, by helping to advance the commercialization of novel diagnostics and medical breakthroughs that help individuals live longer, healthier, more active lives.
The Clinical Trials Consortium is a forum that facilitates dialogue among stakeholders. It organizes, plans, and implements strategies and initiatives designed to grow the region’s clinical research community, give access increased access to cutting edge medicine, engage local physicians in research, and provide high quality job opportunities. In doing this successfully, the consortium will also help to advance the commercialization of novel diagnostics and medical breakthroughs that help people live longer, healthier and more active lives.
The Clinical Trials Consortium is comprised of more than thirty key industry stakeholders from the El Paso, Texas; Juarez, Mexico, and southern New Mexico region. Members include hospital and health systems, physicians, clinical research coordinators, integrated research organizations, diagnostic service providers, academic faculty and others. As the Executive Sponsor, the Medical Center of the Americas Foundation serves as a convener and neutral facilitator for the Clinical Trials Consortium.
If you would like to join the Consortium, please contact Michaele Linden Johnson. You will be added to our distribution list and be notified of future Consortium meetings and events.Contact Now